Evidence map›Paper›PMID 34023470›Full record

ArticleGastroenterologia y hepatologia2022

Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdown.

Laura Sempere, Purificación Bernabeu, José Cameo, Ana Gutierrez, Raquel Laveda, Mariana Fe García, Mariam Aguas, Pedro Zapater, Rodrigo Jover, María Teresa Ruiz-Cantero and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Gastroenterologia y hepatologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laura SempereServicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Alicante, Spain; Group of working on Crohn's Disease and Ulcerative Colitis (GETECCU), Spain.
Purificación BernabeuHealth Psychology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Alicante, Spain. Electronic address: puribernabeu@gmail.com.
José CameoServicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Alicante, Spain; Group of working on Crohn's Disease and Ulcerative Colitis (GETECCU), Spain.
Ana GutierrezServicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Alicante, Spain; Group of working on Crohn's Disease and Ulcerative Colitis (GETECCU), Spain.
Raquel LavedaServicio de Medicina Digestiva, Hospital Universitario de San Juan, Alicante, Spain; Group of working on Crohn's Disease and Ulcerative Colitis (GETECCU), Spain.
Mariana Fe GarcíaServicio de Medicina Digestiva, Hospital General Universitario de Elche, Alicante, Spain; Group of working on Crohn's Disease and Ulcerative Colitis (GETECCU), Spain.
Mariam AguasServicio de Medicina Digestiva, Hospital Universitario y Politécnico la Fe, Valencia, Spain; CIBERESP (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Madrid, Spain; Group of working on Crohn's Disease and Ulcerative Colitis (GETECCU), Spain.
Pedro ZapaterClinical Pharmachology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Alicante, Spain.
Rodrigo JoverServicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Alicante, Spain.
María Teresa Ruiz-CanteroPublic Health Department University of Alicante, Alicante, Spain; CIBERESP (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Madrid, Spain.
Carlos van-der HofstadtHealth Psychology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, Alicante, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with inflammatory bowel disease (IBD) are vulnerable to some psychological disorders. Here we describe the psychological impact of a COVID-19 pandemic lockdown in patients with IBD.

methodsThis multicenter prospective cohort study included 145 patients recently diagnosed with IBD. Data on clinical and demographic characteristics, anxiety and depression scales, and IBD activity were collected in two telephone surveys, during and after the first COVID-19 lockdown in Spain. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.

resultsDuring lockdown, 33.1% and 24.1% scored high on the anxiety and depression scales, respectively. Independent factors related to anxiety (all values ORs; 95% CIs) during lockdown were female sex (2; 1.2-5.4) and IBD activity (4.3; 1.8-10.4). Factors related to depression were comorbidity (3.3; 1.1-9.8), IBD activity (6; 1.9-18.1), use of biologics (2.9; 1.1-7.6), and living alone or with one person (3.1; 1.2-8.2). After lockdown, anxiety and depression symptoms showed significant improvement, with 24.8% and 15.2% having high scores for anxiety and depression, respectively. Factors related to post-lockdown anxiety were female sex (2.5; 1.01-6.3), Crohn's disease (3.3; 1.3-8.5), and active IBD (4.1; 1.2-13.7). Factors associated with depression were previous history of mood and/or anxiety disorders (6.3; 1.6-24.9), active IBD (7.5; 2.1-26.8), and steroid use (6.4; 1.4-29).

conclusionsLockdown during the COVID-19 pandemic had a significant psychological impact in patients with IBD. Disease activity was related to the presence of anxiety and depression symptoms during and after lockdown.

Indexed as

Communicable Disease ControlAdultAnxietyCOVID-19DepressionFemaleHumansInflammatory Bowel DiseasesMaleMiddle AgedProspective StudiesSpainAnsiedadAnxietyCOVID-19DepresiónDepressionEIIIBD

Identifiers

PMID34023470
PMCPMC8807180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.